Form DEF 14C - Other definitive information statements:
SEC Accession No. 0001213900-24-076229
Filing Date
2024-09-06
Accepted
2024-09-05 20:08:33
Documents
2
Period of Report
2024-09-05

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE INFORMATION STATEMENT ea0212108-def14c_elevai.htm DEF 14C 149751
2 GRAPHIC image_001.jpg GRAPHIC 2731
  Complete submission text file 0001213900-24-076229.txt   154837
Mailing Address 120 NEWPORT CENTER DRIVE STE 250 NEWPORT BEACH CA 92660
Business Address 120 NEWPORT CENTER DRIVE STE 250 NEWPORT BEACH CA 92660 18667944940
Elevai Labs Inc. (Filer) CIK: 0001840563 (see all company filings)

EIN.: 851399981 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14C | Act: 34 | File No.: 001-41875 | Film No.: 241282700
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)